Literature DB >> 12873500

Structure--activity relationships of the peptide deformylase inhibitor BB-3497: modification of the P2' and P3' side chains.

Stephen J Davies1, Andrew P Ayscough, R Paul Beckett, John M Clements, Sheila Doel, Lisa M Pratt, Zoë M Spavold, S Wayne Thomas, Mark Whittaker.   

Abstract

Structural modifications to the peptide deformylase inhibitor BB-3497 are described. In this paper, we describe the initial SAR around this lead for modifications to both the P2' and P3' side chains. Enzyme inhibition and antibacterial activity data revealed that a variety of substituents are tolerated at the P2' and P3' positions of the inhibitor backbone. The data from this study highlights the potential for modification at the P2' and P3' positions to optimise the physicochemical properties.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12873500     DOI: 10.1016/s0960-894x(03)00533-x

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  Pharmacokinetics in animals and humans of a first-in-class peptide deformylase inhibitor.

Authors:  Sandhya Ramanathan-Girish; Juliet McColm; John M Clements; Phil Taupin; Sue Barrowcliffe; John Hevizi; Sharon Safrin; Clive Moore; Gary Patou; Heinz Moser; Alison Gadd; Ute Hoch; Vernon Jiang; Denene Lofland; Kirk W Johnson
Journal:  Antimicrob Agents Chemother       Date:  2004-12       Impact factor: 5.191

2.  Comparative QSAR studies on peptide deformylase inhibitors.

Authors:  Ji Young Lee; Munikumar Reddy Doddareddy; Yong Seo Cho; Hyunah Choo; Hun Yeong Koh; Jae-Hoon Kang; Kyoung Tai No; Ae Nim Pae
Journal:  J Mol Model       Date:  2007-02-27       Impact factor: 2.172

3.  Structure-based optimization of a peptidyl inhibitor against calcineurin-nuclear factor of activated T cell (NFAT) interaction.

Authors:  Ziqing Qian; Patrick G Dougherty; Tao Liu; Shameema Oottikkal; Patrick G Hogan; Christopher M Hadad; Dehua Pei
Journal:  J Med Chem       Date:  2014-09-04       Impact factor: 7.446

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.